March 17, 2004 - EAGAN, MN - NutriPhyt, Inc. has selected WGP^® Beta Glucan from Biopolymer Engineering, Inc. as the key ingredient in Imuglucan^TM, a new nutritional supplement to support a healthy immune system.

Imuglucan is designed for physicians and other health care professionals. Clinical and preclinical studies have demonstrated that WGP Beta Glucan enhances the performance of key immune cells called neutrophils, the most abundant immune cell in the human body. WGP Beta Glucan works to prime neutrophils so they kill foreign challenges more efficiently.

The product is manufactured by Labo Phytophar, a Belgian contract manufacturer for health food companies. Imuglucan is manufactured in strict compliance with HACCP and medico-pharmaco technology principles, as well as GMP and pharmaceutical preparation standards.

NutriPhyt is focused on developing products that contain all essential building blocks to keep the body healthy. “We will see to it that everything is done in a scientifically validated way,” said Gabriël Devriendt, NutriPhyt founder. “This means that only natural and standardized products are being used and only substances which have proved to be useful in a certain indication.”

NutriPhyt (Oostkamp, Belgium) was established in 2002. It is the exclusive distributor of WGP Beta Glucan in Belgium, The Netherlands and Luxembourg. Website at www.nutriphyt.be.

Labo Phytophar is located in Belgium. Bart Vergauwe, Pharmacist and general manager of the company, founded Labo Phytophar in June 2000. The tasks of Labo Phytophar include preparing and packaging of nutraceuticals, not only in strict compliance with the current HACCP principles but also with the GMP standards, the medico-pharmaco technology principles and pharmaceutical preparation standards. Michel Legros, certified Industrial Pharmacist, is in charge of quality assurance and plant management.

Biopolymer Engineering, Inc. is a biotechnology company that is pioneering carbohydrate solutions to improve human health. Based in Eagan, Minnesota, the company has more than 40 US patents and patents pending, with additional filings in more than 20 countries that protect its yeast beta glucan products and compounds. Biopolymer Engineering is developing beta glucan applications for pharmaceuticals, nutritional supplements, functional foods, cosmetics and animal feed and nutrition. Website: www.biopolymer.com.

The company’s commercial products are distributed in the U.S. through E.T. Horn. In Europe and Japan, Biopolymer Engineering has an exclusive partnership with DKSH, a leading International Marketing and Services Group (www.dksh.com), to introduce WGP Beta Glucan. The services of DKSH include marketing, sales, project management, distribution, research and development and registration options.

For more information, contact:

David Walsh
Biopolymer Engineering, Inc.
651-256-4606
dwalsh@biopolymer.com